Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Control of B cell development by the histone H2A deubiquitinase MYSM1.

Immunity | 2011

Epigenetic histone modifications play critical roles in the control of gene transcription. Recently, an increasing number of histone H2A deubiquitinases have been identified and characterized. However, the physiological functions for this entire group of histone H2A deubiquitinases remain unknown. In this study, we revealed that the histone H2A deubiquitinase MYSM1 plays an essential and intrinsic role in early B cell development. MYSM1 deficiency results in a block in early B cell commitment and a defect of B cell progenitors in expression of EBF1 and other B lymphoid genes. We further demonstrated that MYSM1 derepresses EBF1 transcription in B cell progenitors by orchestrating histone modifications and transcription factor recruitment to the EBF1 locus. Thus, this study not only uncovers the essential role for MYSM1 in gene transcription during early B cell development but also underscores the biological significance of reversible epigenetic histone H2A ubiquitination.

Pubmed ID: 22169041 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA116677
  • Agency: NIAID NIH HHS, United States
    Id: AI083025
  • Agency: NCI NIH HHS, United States
    Id: R01 CA115284-06A1
  • Agency: NCI NIH HHS, United States
    Id: CA31363
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI068472
  • Agency: NCI NIH HHS, United States
    Id: R01 CA115284
  • Agency: NCI NIH HHS, United States
    Id: CA115284
  • Agency: NIAID NIH HHS, United States
    Id: AI08185
  • Agency: NCI NIH HHS, United States
    Id: R01 CA100841
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI084811
  • Agency: NCI NIH HHS, United States
    Id: CA116677
  • Agency: NCI NIH HHS, United States
    Id: R01CA090427
  • Agency: NIAID NIH HHS, United States
    Id: AI084811
  • Agency: NCI NIH HHS, United States
    Id: CA82057
  • Agency: NIAID NIH HHS, United States
    Id: AI073099
  • Agency: NCI NIH HHS, United States
    Id: R01 CA031363
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090427
  • Agency: NIAID NIH HHS, United States
    Id: AI068472
  • Agency: NCI NIH HHS, United States
    Id: R01 CA137060
  • Agency: NCI NIH HHS, United States
    Id: CA100841

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Miltenyi Biotec (tool)

RRID:SCR_008984

An Organization portal, Antibody supplier, Service resource,

View all literature mentions

International Mouse Phenotyping Consortium (IMPC) (tool)

RRID:SCR_006158

Center that produces knockout mice and carries out high-throughput phenotyping of each line in order to determine function of every gene in mouse genome. These mice will be preserved in repositories and made available to scientific community representing valuable resource for basic scientific research as well as generating new models for human diseases.

View all literature mentions